• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

8-羟基二苯丙氨酸可抑制猫因运动、顺铂或赛拉嗪引起的呕吐。

8-OH-DPAT suppresses vomiting in the cat elicited by motion, cisplatin or xylazine.

作者信息

Lucot J B, Crampton G H

机构信息

Department of Pharmacology and Toxicology, Wright State University, Dayton, OH.

出版信息

Pharmacol Biochem Behav. 1989 Jul;33(3):627-31. doi: 10.1016/0091-3057(89)90399-7.

DOI:10.1016/0091-3057(89)90399-7
PMID:2531422
Abstract

Vomiting was suppressed in cats pretreated with 8-OH-DPAT and then challenged with an emetic stimulus; motion, xylazine or cisplatin. The antiemetic effect is likely due to stimulation of postsynaptic serotonin-1A receptors. The most parsimonious explanation is that it acts at a convergent structure, presumably at or near the vomiting center. If so, 8-OH-DPAT may block emesis elicited by virtually any other stimulus. A supplementary experiment revealed that lorazepam suppressed motion sickness at a dose that produced ataxia, but did not suppress xylazine-induced emesis. These results do not support the possibility that the antiemetic effects of 8-OH-DPAT were the result of anxiolytic activity.

摘要

在用8-羟基二苯丙氨酸预处理并随后用催吐刺激物(运动、赛拉嗪或顺铂)激发的猫中,呕吐受到抑制。其止吐作用可能是由于对突触后5-羟色胺-1A受体的刺激。最简洁的解释是它作用于一个汇聚结构,大概是在呕吐中枢或其附近。如果是这样,8-羟基二苯丙氨酸可能会阻断几乎任何其他刺激引起的呕吐。一项补充实验表明,劳拉西泮以产生共济失调的剂量抑制晕动病,但不抑制赛拉嗪引起的呕吐。这些结果不支持8-羟基二苯丙氨酸的止吐作用是抗焦虑活性结果的可能性。

相似文献

1
8-OH-DPAT suppresses vomiting in the cat elicited by motion, cisplatin or xylazine.8-羟基二苯丙氨酸可抑制猫因运动、顺铂或赛拉嗪引起的呕吐。
Pharmacol Biochem Behav. 1989 Jul;33(3):627-31. doi: 10.1016/0091-3057(89)90399-7.
2
Blockade of 5-hydroxytryptamine3 receptors prevents cisplatin-induced but not motion- or xylazine-induced emesis in the cat.
Pharmacol Biochem Behav. 1989 Jan;32(1):207-10. doi: 10.1016/0091-3057(89)90235-9.
3
Effects of serotonin antagonists on motion sickness and its suppression by 8-OH-DPAT in cats.
Pharmacol Biochem Behav. 1990 Oct;37(2):283-7. doi: 10.1016/0091-3057(90)90335-f.
4
8-OH-DPAT does not interfere with habituation to motion-induced emesis in cats.
Brain Res Bull. 1991 Jun;26(6):919-21. doi: 10.1016/0361-9230(91)90257-k.
5
Antiemetic effects of flesinoxan in cats: comparisons with 8-hydroxy-2-(di-n-propylamino)tetralin.
Eur J Pharmacol. 1994 Feb 21;253(1-2):53-60. doi: 10.1016/0014-2999(94)90756-0.
6
Antiemetic effects of serotonergic 5-HT1A-receptor agonists in Suncus murinus.5-羟色胺能5-HT1A受体激动剂对麝鼩的止吐作用。
Jpn J Pharmacol. 1994 Feb;64(2):109-14. doi: 10.1254/jjp.64.109.
7
Xylazine emesis, yohimbine and motion sickness susceptibility in the cat.赛拉嗪催吐、育亨宾与猫的晕动病易感性
J Pharmacol Exp Ther. 1986 May;237(2):450-5.
8
Buspirone blocks motion sickness and xylazine-induced emesis in the cat.丁螺环酮可阻止猫的晕动病和赛拉嗪引起的呕吐。
Aviat Space Environ Med. 1987 Oct;58(10):989-91.
9
Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.假定的5-羟色胺1A受体对8-羟基-2-(二正丙基氨基)四氢萘(8-OH-DPAT)辨别刺激特性的介导作用
Eur J Pharmacol. 1987 Jan 6;133(1):47-56. doi: 10.1016/0014-2999(87)90204-4.
10
Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3.新型立体选择性8-OH-DPAT类似物(+)顺式-8-羟基-1-甲基-2-(二正丙基氨基)四氢化萘(+)ALK-3的部分突触后5-HT1A激动剂特性
Eur J Pharmacol. 1989 Nov 7;170(3):269-74. doi: 10.1016/0014-2999(89)90549-9.

引用本文的文献

1
The pivotal role of glycogen synthase kinase 3 (GSK-3) in vomiting evoked by specific emetogens in the least shrew (Cryptotis parva).糖原合酶激酶 3(GSK-3)在小臭鼩(Cryptotis parva)对特定催吐物引发呕吐中的关键作用。
Neurochem Int. 2020 Jan;132:104603. doi: 10.1016/j.neuint.2019.104603. Epub 2019 Nov 15.
2
The involvement of TRPV1 in emesis and anti-emesis.瞬时受体电位香草酸亚型1(TRPV1)在呕吐和止吐中的作用。
Temperature (Austin). 2015 May 21;2(2):258-76. doi: 10.1080/23328940.2015.1043042. eCollection 2015 Apr-Jun.
3
Motion Sickness: Current Knowledge and Recent Advance.
晕动病:当前认知与最新进展
CNS Neurosci Ther. 2016 Jan;22(1):15-24. doi: 10.1111/cns.12468. Epub 2015 Oct 9.
4
The broad-spectrum antiemetic effects ETI-385 result from stimulation of 5-HT1A and 5-HT1D receptors.ETI-385的广谱止吐作用源于对5-HT1A和5-HT1D受体的刺激。
Exp Brain Res. 2014 Aug;232(8):2699-707. doi: 10.1007/s00221-014-4004-z. Epub 2014 Jun 10.
5
Identification of neural networks that contribute to motion sickness through principal components analysis of fos labeling induced by galvanic vestibular stimulation.通过对电刺激前庭诱发的fos标记进行主成分分析,识别导致晕动病的神经网络。
PLoS One. 2014 Jan 23;9(1):e86730. doi: 10.1371/journal.pone.0086730. eCollection 2014.
6
Mechanisms, causes, investigation and management of vomiting disorders in cats: a literature review.猫呕吐障碍的机制、病因、调查与管理:文献综述
J Feline Med Surg. 2013 Apr;15(4):237-65. doi: 10.1177/1098612X12473466. Epub 2013 Feb 12.
7
Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus.大麻的非精神活性成分大麻二酚通过在中缝背核中间接激动 5-HT(1A) 体树突自受体,减弱呕吐和类似恶心的行为。
Br J Pharmacol. 2012 Apr;165(8):2620-34. doi: 10.1111/j.1476-5381.2011.01621.x.
8
Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews.大麻中非精神活性大麻素的相互作用:大麻萜酚(CBG)对大麻二酚(CBD)在大鼠和鼩鼱体内抗恶心或止吐作用的影响。
Psychopharmacology (Berl). 2011 Jun;215(3):505-12. doi: 10.1007/s00213-010-2157-4. Epub 2011 Jan 18.
9
Regulation of nausea and vomiting by cannabinoids.大麻素对恶心和呕吐的调节。
Br J Pharmacol. 2011 Aug;163(7):1411-22. doi: 10.1111/j.1476-5381.2010.01176.x.
10
New perspectives in antiemetic treatment.止吐治疗的新视角。
Support Care Cancer. 1996 Nov;4(6):416-9. doi: 10.1007/BF01880638.